Farrall v. AC & S. CO., INC.

558 A.2d 1078, 1989 Del. Super. LEXIS 44
CourtSuperior Court of Delaware
DecidedJanuary 9, 1989
StatusPublished
Cited by9 cases

This text of 558 A.2d 1078 (Farrall v. AC & S. CO., INC.) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Farrall v. AC & S. CO., INC., 558 A.2d 1078, 1989 Del. Super. LEXIS 44 (Del. Ct. App. 1989).

Opinion

TAYLOR, Judge.

Defendants’ have filed a motion in li-mine to bar certain witnesses which plaintiffs propose to have testify.

I. DR. JOSEPH WAGONER

Defendants contend that Dr. Joseph Wagoner should not be permitted to testify with respect to plaintiffs’ fear of cancer. Their first contention is that no expert should be permitted to testify about such fear because this is a subjective matter known only to a plaintiff and those to whom he has spoken on that subject. Applying that position to Dr. Wagoner, they point out that he has never talked to plaintiffs.

Dr. Wagoner has never testified in this Court with respect to any plaintiff’s condition nor has he testified concerning fear which a plaintiff has or the reasonableness of such fear. Cf Lee v. A.C. & S. Co., Inc., DeLSuper., 542 A.2d 352 (1987). He has been permitted to give statistical information concerning disease and death causation as an aid to medical testimony after the foundation has been laid by medical testimony that such statistical information is relied upon by the medical profession in reaching opinions. Id. at 356. If it is anticipated that plaintiffs will seek to elicit this information at the next trial in conjunction with medical testimony, the Court would follow its practice of giving a clarifying instruction such as has been used in the past (if requested by defendants), namely:

Testimony has been given and will hereafter be given regarding possible increased risks of cancer for individuals with asbestos-related diseases. This testimony is admitted in this case only in connection with plaintiffs’ claims based upon alleged fear of developing cancer. None of the plaintiffs claim that they have cancer. There is no claim that plaintiffs will develop cancer. If a plain *1080 tiff ever develops cancer which he contends is caused by asbestos, he can file a new lawsuit. Testimony regarding risks of cancer is to be considered by you solely in deciding whether a plaintiffs claimed fear of developing cancer, if any such fear exists, is reasonable.

Defendants make two contentions in this submission which would be applicable to any testimony by any witness other than a plaintiff. The first is that no expert should be permitted to testify to the reasonableness of a plaintiff's fear and the other is that there should be no recovery for fear of cancer unless there is testimony that a plaintiff has a greater than fifty percent likelihood of developing cancer.

The first contention rests on the proposition that since a plaintiff is permitted to testify about his fear of cancer, no one else can testify on that subject. This contention overlooks the modem approach to evidence. Rule 702 of the Delaware Uniform Rules of Evidence permits expert testimony which “will assist the trier of fact to understand the evidence or to determine a fact in issue”.

Defendants cite Devlin v. Johns-Man-ville Corp., Law Div., 202 N.J.Super. 556, 495 A.2d 495 (1985) as their supporting authority. Devlin considered “whether or not an expert will be needed to testify” concerning fear of cancer. It held that expert testimony would not be required, but it did not hold that expert testimony would be excluded.

I find no reason to bar testimony which would support or refute the reasonableness of the fear which a plaintiff has testified to, recognizing that plaintiff must convince the jury that his expressed fear is a reasonable fear.

Defendants’ remaining contention is that there can be no recovery for fear of a . disease which plaintiff has less than a fifty-one percent likelihood of contracting. Their chief support for that proposition is Lohrmann v. Pittsburgh Coming Corp., 4th Cir., 782 F.2d 1156 (1986). Lohrmann does not support defendants’ contention. In Lohrmann the issue which the District Court excluded was plaintiff’s claim for risk of contracting cancer. In the present case plaintiffs are not claiming for risk of cancer but only for their present fear of getting cancer. The following excerpt demonstrates that Lohrmann does not depart materially from the practice in this Court:

Lohrmann was allowed to testify that he was afraid that he might develop cancer, and cancer was mentioned by other witnesses, but it was hot allowed to become a prominent issue.

Lohrmann, 782 F.2d at 1160.

Lohrmann makes clear that its holding with respect to the fifty-one percent requirement applies only to risk of future cancer by the following quotation from Pierce v. Johns Manville Sales Corp., 296 Md. 656, 464 A.2d 1020, 1026 (1983):

In Maryland, recovery of damages based on future consequences of an injury may be had only if such consequences are reasonably probable or reasonably certain.

Under Delaware law, the fifty-one percent test would entitle the claimant to recover for the probability that the plaintiff would contract cancer and not merely for the fear. The claim based on fear of cancer deals with fear growing out of a past and present condition but it does not deal with a condition which is likely to develop in the future, as is referred to in Lohrm-ann and Pierce.

Finally, defendants cite In re Mooreno-vich, D.Me., 634 F.Supp. 634 (1986) for the proposition that where recovery for a fear of cancer claim is permitted, the court should “be wary of any efforts to ‘overshadow’ the case by the ‘dread spector of cancer’.” This Court concurs in that approach, and to that end has utilized the cautionary instruction to the jury which has been quoted earlier in this decision. It is noted that the court in Moorenovich described the issue which it was considering as follows:

Plaintiffs are seeking damages for a “present” injury. That is, the present anxiety or fear they experience that they will contract cancer in the future. This fear derives from the fact that asbestos is a known carcinogen, that they have *1081 had prolonged exposure to asbestos, and that their co-workers are dying at a higher than normal rate from asbestos-related cancer.

Id. at 636. It is clear that the court in Moorenovich considered that the fact that workers exposed to asbestos were dying from cancer at a higher rate than other workers was a significant factor in the fear claim and, hence, would be testified about.

This Court has consistently held in each trial where a claim for fear of cancer has been involved that evidence of the increased likelihood of cancer would assist the jury in determining whether a plaintiffs fear of cancer is a reasonable fear. Cfi

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Voilas v. General Motors Corp.
73 F. Supp. 2d 452 (D. New Jersey, 1999)
Temple-Inland Forest Products Corp. v. Carter
993 S.W.2d 88 (Texas Supreme Court, 1999)
Owens-Corning Fiberglas Corp. v. Malone
972 S.W.2d 35 (Texas Supreme Court, 1998)
Anderson v. A.P.I. Co. of Minnesota
1997 ND 6 (North Dakota Supreme Court, 1997)
Tormaschy v. Tormaschy - Civil No. 950367
North Dakota Supreme Court, 1997
Beeman v. Manville Corp. Asbestos Disease Compensation Fund
496 N.W.2d 247 (Supreme Court of Iowa, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
558 A.2d 1078, 1989 Del. Super. LEXIS 44, Counsel Stack Legal Research, https://law.counselstack.com/opinion/farrall-v-ac-s-co-inc-delsuperct-1989.